GPAT
GP-Act III Acquisition Corp.10.66
+0.00+0%
Dec 11, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
383.09MP/E (TTM)
31.35Basic EPS (TTM)
0.34Dividend Yield
0%Recent Filings
10-Q
10-Q
Q2 FY2025 results
GP-Act III Acquisition Corp. posted a net income of $2.98M for Q2 2025 ended June 30, up from $1.77M a year earlier, driven by $3.13M in interest from its Trust Account while general and administrative expenses dipped to $141K from $177K. For the first half, net income climbed to $5.89M versus $1.71M last year, with Trust interest surging to $6.23M on higher balances post-IPO. The Trust Account swelled to $303M at $10.54 per share, bolstered by accretion, yet operating cash drained $282K amid a $236K working capital deficit. No business combination yet; liquidity hinges on sponsor advances. Geopolitical tensions pose risks to deal hunting.
10-Q
Q1 FY2025 results
GP-Act III Acquisition Corp. posted a net income of $2.9M for Q1 FY2025 ended March 31, 2025, swinging from a $59.7K loss a year earlier, thanks to $3.1M in interest from its Trust Account while general and administrative expenses climbed to $200.1K from $59.7K. The Trust swelled to $299.8M, up from $296.7M at year-end, as accretion boosted the redemption value to $10.43 per share. Cash outside the Trust dipped to $376.6K, with a $107K q/q drop, yet related-party advances and promissory notes totaling $444.9K keep liquidity afloat amid a $156.3K working capital deficit. No business combination yet; the clock ticks to May 2026. Sponsor shares lock up post-deal. Geopolitical tensions could snag the hunt.
10-K
FY2024 results
GP-Act III Acquisition Corp., a blank check company, completed its IPO in May 2024, raising $287.5 million in gross proceeds from 28.75 million units at $10 each, with funds placed in trust yielding $9.2 million in interest income for the year ended December 31, 2024. No business combination occurred by year-end, leaving the company with $296.7 million in trust assets and $483,572 in cash outside trust, while incurring $565,000 in operating expenses and reporting net income of $8.7 million. Q4 2024 saw sustained momentum in trust growth from interest, with no sequential deterioration but ongoing search costs pressuring liquidity. No capex, dividends, or buybacks occurred; liquidity relies on trust withdrawals for taxes only. No guidance provided. Geopolitical tensions risk delaying the required business combination within 24 months.
10-Q
Q3 FY2024 results
GP-Act III Acquisition Corp. posted a solid Q3 net income of $3.7M, fueled by $3.8M in interest from its $293.2M trust account, up sharply from a $616 loss a year ago as the blank check vehicle had yet to launch its IPO. Operational costs ticked up to $143K from negligible levels, reflecting ramped-up public company expenses. Year-to-date through September 30, 2024, net income hit $5.4M on $5.7M interest, versus a small prior-year loss. Cash outside the trust stands at $514K, with $400K in related-party notes due post-combination; no free cash flow or debt metrics apply pre-deal. The May 2024 IPO raised $287.5M, fully placed in treasuries. Sponsors hold 7.2M founder shares, locking up until a year after any merger. Yet finding a suitable target remains the core challenge amid market volatility.
ASPC
A SPAC III Acquisition Corp.
10.50-0.05
CAEP
Cantor Equity Partners III, Inc
10.20+0.01
CEPT
Cantor Equity Partners II, Inc.
10.85+0.00
CGCT
Cartesian Growth Corporation II
10.11+0.00
GSHR
Gesher Acquisition Corp. II
10.26-0.00
GSRT
GSR III Acquisition Corp.
15.52+1.00
HCMA
HCM III Acquisition Corp.
10.08-0.01
IPCX
Inflection Point Acquisition Co
10.11+0.00
LEGT
Legato Merger Corp. III
10.82-0.01
NPAC
New Providence Acquisition Corp
10.28+0.03